Dibutyl Succinate Bioproduction Engineering Service

Dibutyl Succinate (DBS) is a colorless, odorless liquid used as an environmentally friendly plasticizer, solvent, and flavor/fragrance agent. Conventional production involves esterification of bio-derived or petrochemical succinic acid with butanol, a process characterized by high pollution in chemical synthesis due to catalyst use and side product formation, as well as high energy consumption. Biosynthetic routes suffer from low efficiency in biosynthesis , primarily due to the complex, multi-step enzymatic conversion and insufficient availability of the precursor, butanol.

CD Biosynsis offers a synthetic biology service focused on highly efficient, integrated production of DBS from simple sugars. Our core strategy involves modification of Escherichia coli succinate synthesis pathway . We engineer E. coli to maximize the reductive pathway flux toward succinate (the acid component), typically by deleting competing pathways and optimizing the primary fermentative route. This is coupled with the directed evolution of ester synthase . We introduce and tune a highly efficient, solvent-tolerant ester synthase (e.g., lipase or esterase) that can perform the esterification reaction in vivo or in situ, utilizing the cell's naturally produced butanol (or supplemented butanol) to convert succinate directly to DBS. This integrated approach aims to deliver a high-yield, high-purity, and sustainable DBS product, bypassing the harsh conditions of chemical synthesis.

Pain Points

Developing a cost-competitive biosynthetic route for DBS faces these key limitations:

• High Pollution in Chemical Synthesis: The use of strong inorganic acids as catalysts and the high operating temperatures in the chemical esterification process generate significant waste streams and environmental pollution .
• Low Efficiency in Biosynthesis: The combined need for high titers of two precursors (Succinate and Butanol) and the low activity/stability of the native esterification enzyme result in an overall low conversion rate and product titer .
• Butanol Precursor Toxicity: If butanol is co-produced in the cell, it is often toxic to the host organism (E. coli or yeast), which limits the maximum cell density and final product concentration.
• Pathway Imbalance: Achieving a stoichiometrically balanced supply of both Succinate (C4) and Butanol (C4) precursors for the final esterification step is metabolically challenging.

A successful solution must optimize the production of both precursors and dramatically enhance the efficiency of the final enzymatic esterification step.

Solutions

CD Biosynsis utilizes advanced synthetic biology and enzyme engineering to optimize DBS production in E. coli:

Modification of E. coli Succinate Synthesis Pathway

           

We delete major competing pathways (e.g., lactate, acetate synthesis) and overexpress the reductive pathway (e.g., fumarate reductase) to maximize carbon flux to succinate.

Directed Evolution of Ester Synthase

We use high-throughput screening and directed evolution to engineer a bacterial or fungal ester synthase/lipase with high specific activity and increased tolerance to butanol and organic solvents .

Butanol Pathway Co-optimization

We co-engineer a butanol synthesis pathway (e.g., Clostridial genes) into the host or tune the host's existing alcohol production pathway to ensure sufficient butanol supply for the esterification reaction.

In Situ Product Recovery (ISPR) Integration

We integrate a two-phase system (e.g., liquid-liquid extraction) into the fermenter to continuously remove the hydrophobic DBS product , mitigating both product and butanol toxicity.

This systematic approach is focused on establishing a balanced, high-flux pathway for both acid and alcohol components and enhancing the final enzymatic coupling reaction.

Advantages

Our Dibutyl Succinate engineering service is dedicated to pursuing the following production goals:

Reduced Environmental Footprint

Enzymatic esterification replaces harsh chemical catalysts with a mild, green process, eliminating waste streams.

High DBS Titer

Pathway engineering for both succinate and butanol, coupled with efficient esterification, results in industrially competitive final product concentration .

Optimized Enzyme Performance

Directed evolution yields an ester synthase with high turnover rate and robust stability in the butanol-rich reaction environment. [Image of Cost Reduction Icon]

Bio-based Carbon Source

Production utilizes renewable sugars as the sole carbon source for both the acid and alcohol components, promoting sustainability.

Simplified Downstream Processing

Hydrophobic DBS partitioning into an organic phase via ISPR simplifies recovery and reduces purification costs .

We provide a sustainable and cost-effective biosynthetic platform for industrial DBS production.

Process

Our DBS strain engineering service follows a rigorous, multi-stage research workflow:

• Succinate Pathway Enhancement: Block key byproduct formation pathways (e.g., pta-ackA, ldhA, etc.) and overexpress the CO 2 fixation enzymes to maximize succinate yield.
• Ester Synthase Library Generation: Construct a library of ester synthases/lipases from diverse sources and perform site-saturation mutagenesis to target active site residues.
• Directed Evolution and Screening: Employ a high-throughput colorimetric or fluorescent assay to screen the library for variants with superior specific activity and butanol tolerance.
• Butanol Pathway Integration and Balancing: Integrate and fine-tune the butanol synthesis pathway to achieve a balanced molar ratio of butanol and succinate production.
• Fermentation Performance Validation: Test the final engineered strain in fed-batch fermentation with ISPR to assess DBS titer, yield, and stability .
• Result Report Output: Compile a detailed Experimental Report including gene modification data, enzyme characterization, and fermentation metrics (yield, titer, and purity) , supporting commercialization.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and enzyme performance.

Explore the potential for a high-performance, green DBS supply. CD Biosynsis provides customized strain and enzyme engineering solutions:

• Detailed Titer and Yield Analysis Report , demonstrating success in precursor balancing and final product conversion.
• Consultation on optimized ISPR method design (solvent selection, flow rate, or membrane properties) for maximal product recovery.
• Experimental reports include complete raw data on carbon yield (g DBS/g sugar) and enzyme kinetics (Km, Vmax) of the evolved ester synthase.